Selected research
Industry Growth & Trends
Global Metabolomics Instrument Industry Growth and Trends Forecast to 2032
Market perspective
The global Metabolomics Instrument market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Metabolomics Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Metabolomics Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Metabolomics Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Metabolomics Instrument include Agilent, Metabolon, Bruker, Thermo Fisher, Biotree, Shimadzu Corporation, Biocrates Life Sciences AG, Waters Corporation and Metware, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Metabolomics Instrument market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Metabolomics Instrument market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metabolomics Instrument market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metabolomics Instrument.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Metabolomics Instrument market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Metabolomics Instrument Market by Company
Agilent
Metabolon
Bruker
Thermo Fisher
Biotree
Shimadzu Corporation
Biocrates Life Sciences AG
Waters Corporation
Metware
LECO Corporation
Creative Proteomics
Human Metabolome Technologies
Diagnostic Solutions Laboratory
Applied Protein Technology
Metabolomics Instrument Segment by Type
Mass Spectrometry
Nuclear Magnetic Resonance
Gas Chromatography
Liquid Chromatography
Others
Metabolomics Instrument Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Others
Metabolomics Instrument Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabolomics Instrument market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metabolomics Instrument and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabolomics Instrument.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metabolomics Instrument manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Metabolomics Instrument in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mass Spectrometry
- Nuclear Magnetic Resonance
- Gas Chromatography
- Liquid Chromatography
- Others
Applications
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
Companies covered
- Agilent
- Metabolon
- Bruker
- Thermo Fisher
- Biotree
- Shimadzu Corporation
- Biocrates Life Sciences AG
- Waters Corporation
- Metware
- LECO Corporation
- Creative Proteomics
- Human Metabolome Technologies
- Diagnostic Solutions Laboratory
- Applied Protein Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Metabolomics Instrument Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Metabolomics Instrument Sales Estimates and Forecasts (2021-2032)
- 1.3 Metabolomics Instrument Market by Type
- 1.3.1 Mass Spectrometry
- 1.3.2 Nuclear Magnetic Resonance
- 1.3.3 Gas Chromatography
- 1.3.4 Liquid Chromatography
- 1.3.5 Others
- 1.4 Global Metabolomics Instrument Market Size by Type
- 1.4.1 Global Metabolomics Instrument Market Size Overview by Type (2021-2032)
- 1.4.2 Global Metabolomics Instrument Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Metabolomics Instrument Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Metabolomics Instrument Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Metabolomics Instrument Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Metabolomics Instrument Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Metabolomics Instrument Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Metabolomics Instrument Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Metabolomics Instrument Industry Trends
- 2.2 Metabolomics Instrument Industry Drivers
- 2.3 Metabolomics Instrument Industry Opportunities and Challenges
- 2.4 Metabolomics Instrument Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Metabolomics Instrument Revenue (2021-2026)
- 3.2 Global Top Players by Metabolomics Instrument Sales (2021-2026)
- 3.3 Global Top Players by Metabolomics Instrument Price (2021-2026)
- 3.4 Global Metabolomics Instrument Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Metabolomics Instrument Major Company Production Sites & Headquarters
- 3.6 Global Metabolomics Instrument Company, Product Type & Application
- 3.7 Global Metabolomics Instrument Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Metabolomics Instrument Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Metabolomics Instrument Players Market Share by Revenue in 2025
- 3.8.3 2025 Metabolomics Instrument Tier 1, Tier 2, and Tier 3
4 Metabolomics Instrument Regional Status and Outlook
- 4.1 Global Metabolomics Instrument Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Metabolomics Instrument Historic Market Size by Region
- 4.2.1 Global Metabolomics Instrument Sales in Volume by Region (2021-2026)
- 4.2.2 Global Metabolomics Instrument Sales in Value by Region (2021-2026)
- 4.2.3 Global Metabolomics Instrument Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Metabolomics Instrument Forecasted Market Size by Region
- 4.3.1 Global Metabolomics Instrument Sales in Volume by Region (2027-2032)
- 4.3.2 Global Metabolomics Instrument Sales in Value by Region (2027-2032)
- 4.3.3 Global Metabolomics Instrument Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metabolomics Instrument by Application
- 5.1 Metabolomics Instrument Market by Application
- 5.1.1 Academic and Research Institutes
- 5.1.2 Pharmaceutical and Biotechnology Companies
- 5.1.3 Others
- 5.2 Global Metabolomics Instrument Market Size by Application
- 5.2.1 Global Metabolomics Instrument Market Size Overview by Application (2021-2032)
- 5.2.2 Global Metabolomics Instrument Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Metabolomics Instrument Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Metabolomics Instrument Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Metabolomics Instrument Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Metabolomics Instrument Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Metabolomics Instrument Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Metabolomics Instrument Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Agilent
- 6.1.1 Agilent Company Information
- 6.1.2 Agilent Business Overview
- 6.1.3 Agilent Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Agilent Metabolomics Instrument Product Portfolio
- 6.1.5 Agilent Recent Developments
- 6.2 Metabolon
- 6.2.1 Metabolon Company Information
- 6.2.2 Metabolon Business Overview
- 6.2.3 Metabolon Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Metabolon Metabolomics Instrument Product Portfolio
- 6.2.5 Metabolon Recent Developments
- 6.3 Bruker
- 6.3.1 Bruker Company Information
- 6.3.2 Bruker Business Overview
- 6.3.3 Bruker Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bruker Metabolomics Instrument Product Portfolio
- 6.3.5 Bruker Recent Developments
- 6.4 Thermo Fisher
- 6.4.1 Thermo Fisher Company Information
- 6.4.2 Thermo Fisher Business Overview
- 6.4.3 Thermo Fisher Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Thermo Fisher Metabolomics Instrument Product Portfolio
- 6.4.5 Thermo Fisher Recent Developments
- 6.5 Biotree
- 6.5.1 Biotree Company Information
- 6.5.2 Biotree Business Overview
- 6.5.3 Biotree Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Biotree Metabolomics Instrument Product Portfolio
- 6.5.5 Biotree Recent Developments
- 6.6 Shimadzu Corporation
- 6.6.1 Shimadzu Corporation Company Information
- 6.6.2 Shimadzu Corporation Business Overview
- 6.6.3 Shimadzu Corporation Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Shimadzu Corporation Metabolomics Instrument Product Portfolio
- 6.6.5 Shimadzu Corporation Recent Developments
- 6.7 Biocrates Life Sciences AG
- 6.7.1 Biocrates Life Sciences AG Company Information
- 6.7.2 Biocrates Life Sciences AG Business Overview
- 6.7.3 Biocrates Life Sciences AG Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Biocrates Life Sciences AG Metabolomics Instrument Product Portfolio
- 6.7.5 Biocrates Life Sciences AG Recent Developments
- 6.8 Waters Corporation
- 6.8.1 Waters Corporation Company Information
- 6.8.2 Waters Corporation Business Overview
- 6.8.3 Waters Corporation Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Waters Corporation Metabolomics Instrument Product Portfolio
- 6.8.5 Waters Corporation Recent Developments
- 6.9 Metware
- 6.9.1 Metware Company Information
- 6.9.2 Metware Business Overview
- 6.9.3 Metware Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Metware Metabolomics Instrument Product Portfolio
- 6.9.5 Metware Recent Developments
- 6.10 LECO Corporation
- 6.10.1 LECO Corporation Company Information
- 6.10.2 LECO Corporation Business Overview
- 6.10.3 LECO Corporation Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 LECO Corporation Metabolomics Instrument Product Portfolio
- 6.10.5 LECO Corporation Recent Developments
- 6.11 Creative Proteomics
- 6.11.1 Creative Proteomics Company Information
- 6.11.2 Creative Proteomics Business Overview
- 6.11.3 Creative Proteomics Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Creative Proteomics Metabolomics Instrument Product Portfolio
- 6.11.5 Creative Proteomics Recent Developments
- 6.12 Human Metabolome Technologies
- 6.12.1 Human Metabolome Technologies Company Information
- 6.12.2 Human Metabolome Technologies Business Overview
- 6.12.3 Human Metabolome Technologies Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Human Metabolome Technologies Metabolomics Instrument Product Portfolio
- 6.12.5 Human Metabolome Technologies Recent Developments
- 6.13 Diagnostic Solutions Laboratory
- 6.13.1 Diagnostic Solutions Laboratory Company Information
- 6.13.2 Diagnostic Solutions Laboratory Business Overview
- 6.13.3 Diagnostic Solutions Laboratory Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Diagnostic Solutions Laboratory Metabolomics Instrument Product Portfolio
- 6.13.5 Diagnostic Solutions Laboratory Recent Developments
- 6.14 Applied Protein Technology
- 6.14.1 Applied Protein Technology Company Information
- 6.14.2 Applied Protein Technology Business Overview
- 6.14.3 Applied Protein Technology Metabolomics Instrument Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Applied Protein Technology Metabolomics Instrument Product Portfolio
- 6.14.5 Applied Protein Technology Recent Developments
7 North America by Country
- 7.1 North America Metabolomics Instrument Sales by Country
- 7.1.1 North America Metabolomics Instrument Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Metabolomics Instrument Sales by Country (2021-2026)
- 7.1.3 North America Metabolomics Instrument Sales Forecast by Country (2027-2032)
- 7.2 North America Metabolomics Instrument Market Size by Country
- 7.2.1 North America Metabolomics Instrument Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Metabolomics Instrument Market Size by Country (2021-2026)
- 7.2.3 North America Metabolomics Instrument Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Metabolomics Instrument Sales by Country
- 8.1.1 Europe Metabolomics Instrument Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Metabolomics Instrument Sales by Country (2021-2026)
- 8.1.3 Europe Metabolomics Instrument Sales Forecast by Country (2027-2032)
- 8.2 Europe Metabolomics Instrument Market Size by Country
- 8.2.1 Europe Metabolomics Instrument Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Metabolomics Instrument Market Size by Country (2021-2026)
- 8.2.3 Europe Metabolomics Instrument Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Metabolomics Instrument Sales by Country
- 9.1.1 Asia-Pacific Metabolomics Instrument Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Metabolomics Instrument Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Metabolomics Instrument Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Metabolomics Instrument Market Size by Country
- 9.2.1 Asia-Pacific Metabolomics Instrument Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Metabolomics Instrument Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Metabolomics Instrument Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Metabolomics Instrument Sales by Country
- 10.1.1 South America Metabolomics Instrument Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Metabolomics Instrument Sales by Country (2021-2026)
- 10.1.3 South America Metabolomics Instrument Sales Forecast by Country (2027-2032)
- 10.2 South America Metabolomics Instrument Market Size by Country
- 10.2.1 South America Metabolomics Instrument Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Metabolomics Instrument Market Size by Country (2021-2026)
- 10.2.3 South America Metabolomics Instrument Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Metabolomics Instrument Sales by Country
- 11.1.1 Middle East and Africa Metabolomics Instrument Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Metabolomics Instrument Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Metabolomics Instrument Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Metabolomics Instrument Market Size by Country
- 11.2.1 Middle East and Africa Metabolomics Instrument Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Metabolomics Instrument Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Metabolomics Instrument Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Metabolomics Instrument Value Chain Analysis
- 12.1.1 Metabolomics Instrument Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Metabolomics Instrument Production Mode & Process
- 12.2 Metabolomics Instrument Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Metabolomics Instrument Distributors
- 12.2.3 Metabolomics Instrument Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst